BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1532331)

  • 1. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
    Eigenbrodt E; Reinacher M; Scheefers-Borchel U; Scheefers H; Friis R
    Crit Rev Oncog; 1992; 3(1-2):91-115. PubMed ID: 1532331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate kinase type M2: a crossroad in the tumor metabolome.
    Mazurek S; Grimm H; Boschek CB; Vaupel P; Eigenbrodt E
    Br J Nutr; 2002 Jan; 87 Suppl 1():S23-9. PubMed ID: 11895152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
    Mazurek S
    Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor metabolome.
    Mazurek S; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):1149-54. PubMed ID: 12820363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7.
    Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
    Oncogene; 2001 Oct; 20(47):6891-8. PubMed ID: 11687968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
    Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
    Biochem J; 2001 May; 356(Pt 1):247-56. PubMed ID: 11336658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: role of P36.
    Mazurek S; Hugo F; Failing K; Eigenbrodt E
    J Cell Physiol; 1996 May; 167(2):238-50. PubMed ID: 8613464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.
    Mazurek S; Boschek CB; Eigenbrodt E
    J Bioenerg Biomembr; 1997 Aug; 29(4):315-30. PubMed ID: 9387092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.
    Spoden GA; Rostek U; Lechner S; Mitterberger M; Mazurek S; Zwerschke W
    Exp Cell Res; 2009 Oct; 315(16):2765-74. PubMed ID: 19563799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by glucagon of hepatic pyruvate kinase, 6-phosphofructo 1-kinase, and fructose-1,6-bisphosphatase.
    Pilkis SJ; El-Maghrabi MR; McGrane M; Pilkis J; Claus TH
    Fed Proc; 1982 Aug; 41(10):2623-8. PubMed ID: 6286362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells.
    Gumińska M; Ignacak J; Kedryna T; Stachurska MB
    Acta Biochim Pol; 1997; 44(4):711-24. PubMed ID: 9584851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy.
    Vora S; Halper JP; Knowles DM
    Cancer Res; 1985 Jul; 45(7):2993-3001. PubMed ID: 3159473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas.
    Eigenbrodt E; Basenau D; Holthusen S; Mazurek S; Fischer G
    Anticancer Res; 1997; 17(4B):3153-6. PubMed ID: 9329624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF.
    Schmidt M; Kammerer U; Segerer S; Cramer A; Kohrenhagen N; Dietl J; Voelker HU
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):72-8. PubMed ID: 18394773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors.
    Eigenbrodt E; Leib S; Krămer W; Friis RR; Schoner W
    Biomed Biochim Acta; 1983; 42(11-12):S278-82. PubMed ID: 6326772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
    Mazurek S; Drexler HC; Troppmair J; Eigenbrodt E; Rapp UR
    Anticancer Res; 2007; 27(6B):3963-71. PubMed ID: 18225557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
    Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
    J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
    Kumar Y; Tapuria N; Kirmani N; Davidson BR
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative detection of tumor M2-PK in serum and plasma.
    Hugo F; Fischer G; Eigenbrodt E
    Anticancer Res; 1999; 19(4A):2753-7. PubMed ID: 10470235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.